Delivery Order SPE2DR25D3015-SPE2DR26F4FM4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,458.54 to AmerisourceBergen Drug Corp for the supply of Aplenzin ER 348 mg tablets (30-count package) on September 17, 2025, with completion targeted for September 18, 2025. This non-competitive delivery order was issued on a firm fixed-price basis and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract action under AmerisourceBergen's broader...
- The Defense Logistics Agency (DLA) awarded a $11,604.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Aplenzin ER 174 mg tablets (30-count units) effective December 11, 2025, with completion targeted for December 12, 2025. This non-set-aside competitive award was fulfilled by AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, the company's headquarters location and place of performance. The delivery order represents a child contract...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $36,537.34 firm fixed-price delivery order is for the supply of APLENZIN ER 522 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of March 3, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,815.42, is for the delivery of APLENZIN ER 348 MG TABLET 30S, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $2,940.29 to Amerisourcebergen Drug Corporation for 348 mg Aplenzin ER tablets. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by July 11, 2023 in accordance with the terms set forth in the contract. As the Defense Logistics Agency is responsible for worldwide logistics support...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,512.09 firm fixed-price contract is for the delivery of the pharmaceutical product APLENZIN ER 348 MG TABLET 30S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, to provide the pharmaceutical product Aplenzin ER 174 mg tablets. The contract has a ceiling value of $10,273.64 and a performance period through March 19, 2024. AmerisourceBergen Drug Corp is also the prime contractor on a separate indefinite delivery contract (IDC) with DLA Troop Support Medical,...
- This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,523.29, is for the delivery of the pharmaceutical product APLENZIN ER 522 MG TABLET 30S. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 19, 2025. It is not associated with a set-aside designation. AmerisourceBergen holds a significant Indefinite...
- The Defense Logistics Agency awarded a delivery order contract valued at $11,752.80 to AmerisourceBergen Drug Corp on December 16, 2025, with completion expected by December 17, 2025. This firm fixed-price delivery order was issued without set-aside designation and represents a competitively awarded contract for pharmaceutical supply. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. As a child contract under a larger vehicle, this delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $12,778.22 by the Defense Logistics Agency for the supply of Attruby 356 mg tablets (28-count packages) with a firm fixed price structure. The award, made on May 8, 2025, carries an ultimate completion date of May 30, 2025, and represents a competitive award with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger...
- SPE2DR25D3015Indefinite Delivery Contract
- SPE2DR25D3015-SPE2DR26F4FM4Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,319.92 to supply Aplenzin ER 348 mg tablets (30-count) under a firm fixed price contract. The award, issued December 16, 2025, with completion targeted for December 17, 2025, represents a non-competitive, non-set-aside delivery order. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office location at the same address. This delivery order is a child contract under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply medications, vaccines, medical devices, and specialized healthcare commodities to military healthcare systems worldwide. AmerisourceBergen Drug Corp's demonstrated capability in managing diverse pharmaceutical procurement requirements through open competition has positioned it as a critical vendor for federal medical supply needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 12/15/25 |